ICICI likely to issue long-term bonds, Axis mulls infra bond sale
Company will use money to promote brands, increase offline distribution, and expand internationally
To float AA-rated 10-year NCDs at a lower rate of interest than the 5.37% coupon on dollar-denominated senior secured notes due for repayment in April 2024
The fintech firm aims to cross an AUM of over $1 billion in the next 6-9 months
Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors. The company's board has approved a Qualified Institutional Placement (QIP) programme to raise Rs 500 crore, it said in a regulatory filing. With this QIP, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 per cent stake in it by March 2023. Post a successful turnaround of the Insolvency Bankruptcy Code case, the company has been on a growth spree, it said. On the back of a robust product launch pipeline and an agile management team, the company said it is poised to become an even stronger player in the Cephalosporin antibiotics space.
Facility supported by MUFG Bank and Sumitomo Mitsui Banking Corporation with equal participation
The Mumbai based lender is likely to come up with another offering of AT1 bonds before the close of the current financial year (FY23)
The fund-raising would be conducted through a combination of $640 million (Rs 5,100 crore) in equity shares and $475 million (Rs 3,800 crore) through equity share warrants, YES Bank had said
Adani Enterprises Ltd chose a fundraising route for its $2.5 billion share sale that allows the group to woo retail investors through potentially discounted prices
Public sector lender plans tier I bond of Rs 700 crore before financial year closes
RIL's rights issue in 2020 for Rs 53,124 cr remains the single-biggest equity issuance by an Indian firm
Microfinance lender Spandana Sphoorty Financial will raise up to Rs 300 crore by issuing bonds next week, the company said on Wednesday. The board of directors in a meeting held on November 16, 2022, has approved to issue market-linked rated non-convertible debentures (NCDs) with a base issue size of Rs 200 crore and green shoe option of Rs 100 crore, the company said in a regulatory filing. The tenure of bonds, to be allotted on November 22, 2022, have a tenure of 18 months. The company said the bonds will carry interest at 11.15 per cent per annum. Shares of Spandana Sphoorty closed 1.81 per cent down at Rs 560.65 apiece on BSE.
Firm provides affordable diabetes care with a focus on people who don't have access to specialists
Digital solution provider for diabetic patients BeatO on Wednesday said it raised USD 33 million (around Rs 269 crore) in Series B funding led by Lightrock India with participation from HealthQuad, Flipkart and existing investors. Founded by Gautam Chopra, Yash Sehgal and Kunal Kinalekar, the startup claims to provide affordable, comprehensive and patient-centric digital solutions to people with diabetes, who have limited access to good quality and continuous care. The fresh funds will be utilised to expand BeatO's diabetes care programmes pan-India, invest in strengthening the leadership team and to further invest in its product and technology, the startup said in a statement. The company will also continue to build the evidence base for its care programmes, setting the standard of care globally for diabetes as it aims to serve over 10 million patients by 2025, it added. "With our digital-first solution, BeatO is well positioned to lay the new standards of how care will be deliver
Georgian's Lead Investor Emily Walsh will join the Contentstack board along with Contentstack CFO David Overmyer
Company says it will 'aggressively expand' presence in US, Africa and West Asia
Funds will be used to help countries prevent future pandemics; fundraising currently at $1.4 billion
Keystone Realtors, which sells properties under the brand 'Rustomjee', on Friday said it has collected a little over Rs 190 crore from anchor investors days before its initial public offering (IPO). The company has decided to allot 35.21 lakh equity shares to 16 anchor investors at Rs 541 apiece, taking the transaction size to Rs 190.5 crore, according to a circular uploaded on BSE website. The anchor book saw participation from a wide variety of investors. Abu Dhabi Investment Authority, Morgan Stanley and Saint Capital accounted for nearly 35 per cent of the anchor investor portion. Domestic mutual funds such as Aditya Birla Mutual Fund, IDFC Mutual Fund, Tata Mutual Fund and Quant Mutual Fund also participated in the anchor investor portion. SBI Life Insurance and HDFC Life Insurance Company too were part of the anchor investors. The Mumbai-based company is looking to raise Rs 635 crore through the IPO, which consists of a fresh issue of equity shares aggregating up to Rs 560
The government intends to raise 160 billion rupees ($2 billion) via the issue in the January-March quarter.
LT Foods Ltd on Thursday said it has raised nearly Rs 390 crore by selling shares to Saudi Agricultural and Livestock Investment Company (SALIC) through private placement. In a regulatory filing, the company informed that its board has approved issuance and allotment by way of a preferential allotment on a private placement basis up to 27,408,164 equity shares at a price of Rs 142.23 per share for cash consideration of up to Rs 389.82 crore. The preferential issuance of 27,408,164 equity shares is equivalent to 7.89 per cent equity stake in LT Foods, at Rs 142.23 per share to SALIC, a Saudi Joint Stock Company that is owned by the Public Investment Fund of the Kingdom of Saudi Arabia. In addition, SALIC will acquire a 1.33 per cent equity stake through a secondary share purchase from the promoters group. "Post completion of this transaction, SALIC will hold a 9.22 per cent equity stake in LT Foods. The promoters of the company will continue to hold the majority equity stake of 51 p